Occupation or Discipline – Page 5

Johnson & Johnson Announces $55 Billion Investment in U.S. Manufacturing and Innovation

4 months ago talkbio0Tagged aligns, announcement, Benefit, capabilities, commitment, Corporation, domestic pharmaceutical industry, Increased, innovation, Investments, J&J 's, Manufacturing, Surgical construction, trends qualifier, United States

This major investment demonstrates J&J’s commitment to expanding its U.S. manufacturing and innovation capabilities, with potential benefits for job creation and the domestic pharmaceutical industry. The announcement aligns with broader trends of increased U.S. manufacturing investment by large corporations in recent years.

Dexcom survey shows healthcare providers opt for CGM tech over new medications in Type 2 diabetes

4 months ago talkbio0Tagged CGM, Continuous Glucose Monitoring System, Diabetes Mellitus, Non-Insulin-Dependent, Health Personnel, Technology

Continuous Glucose Monitoring System, Technology, Health Personnel, CGM, Diabetes Mellitus, Non-Insulin-Dependent

Six Payer Trends Shaping Market Access in 2025

4 months ago talkbio0Tagged 2025, Access, Artificial Intelligence, Enrollment, Market, payer, payers, Shapes, trends qualifier

Market, trends qualifier, Access, Enrollment, 2025, payer, Shapes, payers, Artificial Intelligence

MeiraGTx and Hologen AI Form $430M Collaboration to Advance Parkinson’s Gene Therapy

5 months ago talkbio0Tagged Artificial Intelligence, Biotechnology, Clinical Trials, gene therapy, Parkinson 's disease

gene therapy, Parkinson’s disease, artificial intelligence, clinical trials, biotechnology partnership

Advancing Aseptic Manufacturing: GRAM’s Vision for the Future of Sterile Drug Production

5 months ago talkbio0Tagged Advanced phase, Annex 1, aseptic manufacturing, Automation, capabilities, Drug Delivery Systems, fill-finish, Flexible, isolator technology, Patient-centric solutions, Regulatory Compliance, Robotics, strategic partnerships

Aseptic manufacturing , Isolator technology, Automation and robotics, Flexible fill-finish capabilities, Advanced drug delivery systems, Regulatory compliance (Annex 1), Strategic partnerships, Patient-centric solutions